Literature DB >> 30590322

Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer.

Sile Liu1, Yuting Zhan1, Jiadi Luo1, Juan Feng1, Junmi Lu1, Hongmei Zheng1, Qiuyuan Wen1, Songqing Fan2.   

Abstract

Lung cancer, with about 85% being non-small cell lung cancer (NSCLC), is one of the most common malignant tumors and the leading cause of cancer-related death in both men and women. Exosomes are defined as extracellular vesicles with a diameter of 30-100 nm, containing proteins, nucleic acids, lipids, etc., which are secreted by various cells in the microenvironment. Increasing evidences implicate that exosomes act as important molecular vehicles participating in physiological and pathological processes, such as tumor initiation, progression, and response to therapy in a number of human cancers including NSCLC. The aim of this review is to disclose the function of exosomes in NSCLC carcinogenesis, and discuss the potential clinical significance in the diagnosis, prognosis and of treatment NSCLC.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Biomarkers; Carcinogenesis; Exosomes; NSCLC; Therapy

Mesh:

Substances:

Year:  2018        PMID: 30590322     DOI: 10.1016/j.biopha.2018.12.088

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  19 in total

1.  miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.

Authors:  Xingju Zhang; Fei Li; Ying Tang; Qinglan Ren; Bin Xiao; Ying Wan; Shan Jiang
Journal:  Oncogene       Date:  2020-08-27       Impact factor: 9.867

Review 2.  Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.

Authors:  Tianjiao Geng; Patrick Pan; Euphemia Leung; Qi Chen; Larry Chamley; Zimei Wu
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

3.  Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients.

Authors:  Eleni-Kyriaki Vetsika; Priyanka Sharma; Ioannis Samaras; Alexandra Markou; Vassilis Georgoulias; Theresa L Whiteside; Athanasios Kotsakis
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 4.  Exosomes: a new perspective in EGFR-mutated lung cancer.

Authors:  Amina Jouida; Cormac McCarthy; Aurelie Fabre; Michael P Keane
Journal:  Cancer Metastasis Rev       Date:  2021-04-14       Impact factor: 9.264

Review 5.  Extracellular vesicles: novel communicators in lung diseases.

Authors:  Aradhana Mohan; Stuti Agarwal; Matthias Clauss; Nicholas S Britt; Navneet K Dhillon
Journal:  Respir Res       Date:  2020-07-08

Review 6.  A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells.

Authors:  Ancuta Jurj; Oana Zanoaga; Cornelia Braicu; Vladimir Lazar; Ciprian Tomuleasa; Alexandru Irimie; Ioana Berindan-Neagoe
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

7.  Effect of thoracic paraspinal block-propofol intravenous general anesthesia on VEGF and TGF-β in patients receiving radical resection of lung cancer.

Authors:  Yang Sen; Hu Xiyang; Han Yu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Upregulation of E-cadherin in bronchoalveolar lavage fluid-derived exosomes in patients with lung cancer.

Authors:  Ying Zhang; Ziyu Liu; Shanyu Li; Manning Wang; Dayou Dai; Hongyu Jing; Lingyun Liu
Journal:  Thorac Cancer       Date:  2019-11-06       Impact factor: 3.500

Review 9.  Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases.

Authors:  Abdul Q Khan; Sabah Akhtar; Kirti S Prabhu; Lubna Zarif; Rehan Khan; Majid Alam; Joerg Buddenkotte; Aamir Ahmad; Martin Steinhoff; Shahab Uddin
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

Review 10.  Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.

Authors:  Erika Rijavec; Simona Coco; Carlo Genova; Giovanni Rossi; Luca Longo; Francesco Grossi
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.